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Abstract 18 
 19 
An effect of the vitamin A metabolite all-trans-retinoic acid (ATRA) on body weight regulation and 20 
adiposity has been described, but little is known about its impact on obesity-associated inflammation. Our 21 
objective was to evaluate the overall impact of this metabolite on inflammatory response in human and 22 
mouse adipocytes, using high-throughput methods, and to confirm its effects in a mouse model. ATRA (2 23 
µM for 24 h) downregulated the mRNA expression of 17 chemokines in human adipocytes, and limited 24 
macrophage migration in a TNFα-conditioned 3T3-L1 adipocyte medium (26.3%, p < 0.05). These effects 25 
were confirmed in mice (n = 6-9 per group) subjected to oral gavage of ATRA (5 mg/kg of body weight) 26 
and subsequently injected intraperitoneally with lipopolysaccharide. In this model, both systemic and 27 
adipose levels of inflammatory markers were reduced. The anti-inflammatory effect of ATRA was 28 
associated with a reduction in the phosphorylation levels of IκB and p65 (~ 50%, p < 0.05), two subunits 29 
of the NF-κB pathway, probably mediated by PGC1α, in 3T3-L1 adipocytes. Taken together, these results 30 
show a significant overall anti-inflammatory effect of ATRA on proinflammatory cytokine and chemokine 31 
production in adipocyte and adipose tissue and suggest that ATRA supplementation may represent a 32 
strategy of preventive nutrition to fight against obesity and its complications. 33 
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37 
Introduction 38 
 39 
The inflammatory response triggered by obesity involves many components of the classical inflammatory 40 
response to pathogens, and is thought to play a major role in the onset of insulin resistance [1]. The main 41 
source of pro-inflammatory cytokines in obesity is adipose tissue [2]. Various products of adipose tissue 42 
have been characterized. Among the soluble factors it produces are the adipokines: these include leptin, 43 
adiponectin, tumor necrosis factor-alpha (TNFα), interleukin-6 (IL6), interleukin-1β (IL1β), and 44 
chemokines [3]. These cytokines are mainly produced by infiltrating macrophages, although adipocytes 45 
play a role [4]. 46 
Adipose tissue is also considered as the second most important storage site for retinol after the liver [5, 6]. 47 
Other retinoids including several isomers of retinoic acid, of which all-trans-retinoic acid (ATRA) and 48 
retinaldehyde, have been detected in this tissue [7, 8].  49 
Many studies indicate that vitamin A inadequacy is associated with obesity, and that vitamin A may play 50 
an important role in body weight regulation and adiposity in humans (for a review [9]). Many animal and 51 
in vitro studies have demonstrated the role of vitamin A metabolites in the control of adiposity (for a review 52 
[10]). Notably, the action of ATRA has been linked to increased oxidative metabolism and energy 53 
expenditure in different tissues including white adipose tissue (WAT) [10, 11], and could be related to the 54 
ability of ATRA to impact oxidative phosphorylation (OXPHOS) capacity and mitochondrial content in 55 
adipocytes [12].  56 
The per se anti-inflammatory effect of ATRA has not yet been thoroughly investigated in adipocytes. A 57 
few studies have reported that ATRA can regulate the production of several adipokines linked to 58 
inflammatory tone, including leptin, adipsin and resistin. An inhibitory effect of ATRA on leptin 59 
expression has been described [13, 14]. ATRA also suppressed the adipose production of resistin [15] in 60 
vivo and in adipocyte cell models. Similarly, adipsin was downregulated by ATRA in adipocyte cell culture 61 
[16]. Our group has shown that ATRA is able to limit the expression of pro-inflammatory markers (IL6 and 62 
IL1β) in murine adipocytes pretreated with ATRA and incubated with TNFα [17]. 63 
The aim of the present study was to extend current knowledge on the impact of the active form of vitamin 64 
A (ATRA) on inflammatory responses in human and mouse adipocytes, using high-throughput methods, 65 
and to confirm its effects in the adipose tissue of an inflammatory animal model.  66 
 67 
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1. Materials and Methods 92 
 93 
1.1. Reagents - Dulbecco’s modified Eagle’s medium (DMEM) was purchased from Life Technologies 94 
(Cergy-Pontoise, France). Fetal bovine serum (FBS) was obtained from PAA Laboratories (Les Mureaux, 95 
France). Isobutylmethylxanthine, dexamethasone and insulin were purchased from Sigma-Aldrich (Saint-96 
Quentin-Fallavier, France). TRIzol reagent, random primers and Moloney murine leukemia virus reverse 97 
transcriptase were obtained from Life Technologies (Saint-Aubin, France). SYBR Green reaction buffer 98 
was purchased from Eurogentec (Angers, France). 99 
 100 
1.2. Cell culture - Macrophage and adipocyte cells were grown at 37 °C in a 5% CO2 humidified 101 
atmosphere. The 3T3-L1 preadipocytes (ATCC, Manassas, VA; passage 10) were seeded in 3.5 cm 102 
diameter dishes at a density of 15 × 104 cells/well, and grown in DMEM supplemented with 10% FBS, at 103 
37 °C, as previously described [18]. To induce differentiation, two-day postconfluent 3T3-L1 preadipocytes 104 
(day 0) were stimulated for 72 h with 0.5 mM isobutylmethylxanthine, 0.25 µmol/L dexamethasone and 1 105 
µg/mL insulin in DMEM supplemented with 10% FBS. The cultures were then treated with DMEM 106 
supplemented with 10% FBS and 1 µg/ml insulin (complete medium). In most cases, adipocytes were 107 
preincubated with all-trans-retinoic acid (ATRA) (0.2 and 2 µM; dissolved in absolute ethanol) for 24 h 108 
and incubated with TNFα (15 ng/mL) for an additional 24 h. To identify the signaling pathway involved in 109 
chemokine regulation, 3T3-L1 cells were treated with a specific inhibitor of NF-κB signaling (BAY 110 
117082, 10 µM) for 1 h, and then stimulated with TNFα (15 ng/mL) for 24 h. To examine ATRA effects 111 
on NF-κB signaling, adipocytes were incubated with TNFα (15 ng/ml) for 5 min. All treatments were 112 
performed on day 8. Each experiment was reproduced in triplicate, at least 3 independent times. To examine 113 
the impact of PGC1α and PGC1β on NF-κB signaling, adipocytes were transfected with pCMX-PGC1α or 114 
pCMX-PGC1β for 24 h, and then incubated with TNFα (15 ng/ml) for 5 min. 115 
Raw 264.7 macrophages (ECACC, Salisbury, UK; passage 8) were seeded in 3.5 cm diameter dishes and 116 
grown in DMEM supplemented with 10% FBS, 2% HEPES and 1% antibiotics. 117 
The human preadipocytes (five independent cultures) were supplied by Promocell (Heidelberg, Germany) 118 
and cultured according to the company’s instructions. The mature adipocytes (day 15) were incubated with 119 
ATRA (2 µM, 24 h) followed by a 24 h incubation with TNFα (15 ng/mL). Experiments were performed 120 
in triplicate, on 3 independent times. 121 
 122 
1.3. Microarray hybridization and data analysis - RNA was extracted from human adipocyte cultures 123 
(three independent cultures), and RNA quality control was performed on an Agilent 2100 Bioanalyzer 124 
(Massy, France), according to the manufacturer’s instructions. RNA was hybridized to the Agilent Whole 125 
Human Genome 860K microarray (Massy, France). For each independent culture, treated conditions 126 
(ATRA + TNFα) were labeled with cyanine 5, and control conditions (TNFα alone) with cyanine 3. In 127 
addition, a treated pool and a control pool made from an equal amount of each independent control and 128 
treated condition were made up and labeled likewise (treated pool with cyanine 5 and control pool with 129 
cyanine 3). The resulting four pairs of samples (three independent pairs of samples plus one pair of pooled 130 
samples) were further hybridized. All labeling, hybridization, washing and scanning were performed as 131 
described in the manufacturer’s protocol and as previously described [17, 19]. The same procedure was 132 
applied for 3T3-L1 adipocytes treated only with ATRA. 133 
The arrays were scanned using an Agilent Scanner (Massy, France). The data were extracted using Agilent 134 
Feature Extraction v10.5.1.1 software and analyzed with Agilent GeneSpring GX v11.0.2 software (Massy, 135 
France). The analyses were performed using GSEA (http://www.broadinstitute.org/gsea) (Gene Set 136 
Enrichment Analysis) and DAVID (Database for Annotation, Visualization, and Integrated Discovery) 137 
software as previously described [20]. A false discovery rate q < 0.25 for normalized enrichment score was 138 
considered significant. 139 
 140 
1.4. RNA isolation and qPCR - Total cellular RNA was extracted using TRIzol reagent according to the 141 
manufacturer’s instructions. cDNA was synthesized from 1 µg of total RNA using random primers and 142 
Moloney murine leukemia virus reverse transcriptase. Real-time quantitative RT-PCR analyses were 143 
performed using the Mx3005P Real-Time PCR System (Stratagene, La Jolla, CA) as previously described 144 
[21]. For each condition, the expression was quantified in duplicate, and the ribosomal protein 18S mRNA 145 
was used as the endogenous control in the comparative cycle threshold (CT) method. The sequences of the 146 
primers used for qPCR determination of gene expression are displayed in Table S1.  147 
 148 
1.5. Chemokine quantification in cell culture supernatants – A Proteome ProfilerTM Array Human 149 
Chemokine Array Kit, Catalog Number ARY017 (R&D Systems (Lille, France)) was used to quantify 31 150 
chemokines in human adipocyte cell culture supernatants according to the manufacturer’s instructions. 151 
Pixel density was quantified with Image J software. A Luminex screening assay (R&D Systems (Lille, 152 
France)) was also used to quantify CXCL10 with the Luminex 200 platform. 153 
 154 
1.6. Chemokine/cytokine quantification in plasma and epididymal adipose tissue samples – Ccl2 and 155 
Ccl5 were quantified with mouse Ccl2 and Ccl5 DuoSet ELISA from R&D Systems. Tnfα and Il6 were 156 
quantified with Ready-SET-Go! ELISA from eBioscience. 157 
 158 
1.7. Macrophage migration assay - Migration assays were performed using cell culture inserts of 3 μm 159 
membrane pore size (Transwell Millipore, Molsheim, France). The 3T3-L1 adipocytes were preincubated 160 
with or without various concentrations of ATRA (0.2 and 2 µM) for 24 h. The adipocytes were then 161 
incubated with TNFα (15 ng/mL) for 24 h. The 3T3-L1 conditioned media were transferred to plates 162 
containing inserts. RAW 264.7 macrophages (ECACC, Salisbury, UK) were seeded on these inserts at a 163 
density of 900 cells/cm2. After migration for 4 h at 37 °C, macrophages in the lower compartment were 164 
fixed with 2.5% glutaraldehyde for 15 min, and counted as previously described [22-24]. 165 
 166 
1.8. NF-κB activation – To examine ATRA effects on NF-κB signaling, adipocytes were preincubated 167 
with ATRA (0.2 and 2 µM) for 24 h and incubated with TNFα (15 ng/mL) for an additional 5 min. 168 
Phosphorylation levels of p65 (Ser536) and IκBα (Ser32/36) were quantified with an ELISA Instant One 169 
kit according to the manufacturer’s instructions (eBiosciences SAS, Paris, France).  170 
 171 
1.9. Transfection experiments – For RNA interference experiments, 3T3-L1 differentiated cells were 172 
transfected with siRNA targeted against Ppargc1α or Ppargc1β (encoding peroxisome proliferator-activated 173 
receptor gamma coactivator (PGC)1α or PGC1β, respectively) or a nontargeting siRNA according to the 174 
manufacturer’s instructions (Polyplus). Briefly, the cells were transfected overnight using a mixture of 10 175 
µM siRNA and 2.8 µL of interferin reagent per well. The media were then replaced with complete medium. 176 
Adipocytes were then treated with ATRA for 24 h, and incubated for a further 24 h. 177 
For overexpression experiments, 3T3-L1 adipocytes were transfected using Lipofectamine LTX Plus 178 
Reagent (Life Technologies) with empty or PGC1α-containing pCMX plasmid (pCMX-PGC1α; Addgene 179 
plasmid # 6 [25]). After 24 h incubation with transfection mixes (1 µg of plasmid, 0.9 µL of Lipofectamine 180 
LTX and 1 µL of Plus Reagent per well, according to the manufacturer’s instructions), the medium was 181 
replaced, and cells were incubated with TNFα for 24 h. RNA was isolated from treated cells, and residual 182 
plasmidic DNA contamination was removed by DNase I digestion (Sigma-Aldrich (Saint-Quentin-183 
Fallavier, France)). PGC1α expression was quantified by qPCR. 184 
  185 
1.10. Animal experiment – The protocol was approved by the local ethics committee. Six-week-old male 186 
C57BL/6J mice were obtained from Janvier (Le Genest-Saint-Isle, France). Mice were fed ad libitum (chow 187 
diet A04, Safe, Augy, France), with full access to drinking water. The animals were maintained at 22 °C 188 
under a 12 h light – 12 h dark cycle at 50% humidity.  189 
To assess the impact of vitamin A on acute inflammation, the mice received by gavage (n = 6–9 per group) 190 
the active form of vitamin A (ATRA) (5 mg/kg of body weight; Sigma-Aldrich, Saint-Quentin-Fallavier, 191 
France) or vehicle alone (olive oil), once a day for 4 days. On the fifth day, the mice were injected 192 
intraperitoneally with saline or Escherichia coli lipopolysaccharide (LPS) (4 mg/kg; serotype O111:B4, 193 
Sigma-Aldrich). The mice were sacrificed 4 h after LPS injection, and epidydimal adipose tissue was 194 
dissected and stored at −80 °C.  195 
 196 
1.11. Statistical analysis - The data are expressed as means ± SEM. Significant differences between the 197 
control and treated group were determined using the ANOVA analysis followed by the Tukey-Kramer post 198 
hoc test using Statview software: p < 0.05 was considered statistically significant. 199 
  200 
2. Results 201 
 202 
2.1. ATRA modulates the transcriptome of human adipocytes in inflammatory conditions. 203 
To study the impact of ATRA on chemokines under inflammatory conditions, these cells were preincubated 204 
with ATRA, or untreated, and then incubated with TNFα. The transcriptomic approach was applied in cells 205 
treated with TNFα compared with cells pretreated with ATRA before incubation with TNFα. The impact 206 
of these treatments on the transcriptome was evaluated with a fold change filter of 1.3. Examination of the 207 
gene list by DAVID (Database for Annotation, Visualization, and Integrated Discovery) software revealed 208 
that the “chemokine family” was strongly impacted by the ATRA / TNFα treatment compared with TNFα 209 
alone (P-Value = 0.018) (Table S1). These data were confirmed by other software, GSEA (Gene Set 210 
Enrichment Analysis), with which analysis according to gene ontology terms highlighted inflammation 211 
related processes such as “G protein coupled receptor binding”, “defense response”, “locomotory 212 
behavior”, “cytokine activity” and “chemokine activity”. The chemokine activity was impacted by the 213 
ATRA / TNFα treatment compared with TNFα alone (NES = −1.757, p < 0.05 and FDR q < 0.25; the ten 214 
most frequently represented gene sets are given in Table S2). It is noteworthy that all these gene sets 215 
presented a negative enrichment score, meaning that chemokines were downregulated by ATRA 216 
pretreatment in comparison with TNFα (Table S2). As seen in Table S3, 17 chemokines identified by GSEA 217 
software were regulated by ATRA pretreatment in human adipocytes. Interestingly, we also observed that 218 
five chemokine receptors were downregulated by ATRA pretreatment (Table S4). To confirm our 219 
observations, we evaluated the gene expression profiles of six chemokines (randomly chosen, CCL5, 220 
CCL19, CX3CL1, CXCL1, CXCL5 and CXCL10) in human adipocytes incubated with ATRA (2 µM) for 221 
24 h followed or not by incubation with TNFα (15 ng/mL) for a further 24 h. A significant increase in 222 
expression was observed in all the genes investigated: CCL5, CCL19, CXCL1, CX3CL1, CXCL5 and 223 
CXCL10 were increased 1611%, 2194%, 1865%, 993%, 3221% and 493%, respectively, in TNFα condition 224 
vs. control (Figure 1A). Interestingly, the incubation with ATRA reduced the mRNA expression levels of 225 
these chemokines 57.7%, 92.6%, 816.5%, 67.8%, 55.5% and 54.4%, respectively, compared withTNFα 226 
alone. 227 
Very similar results were obtained when murine 3T3-L1 differentiated adipocytes were treated: the mRNA 228 
expression levels of Ccl5, Ccl19, Cxcl1, Cx3cl1 and Cxcl10 were significantly increased by TNFα 34163%, 229 
3489%, 729%, 211%, and 1221%, respectively. By contrast, ATRA incubation significantly reduced 230 
chemokine expression in comparison with the TNFα condition 49%, 92.3%, 60.6%, 80.1% and 20%, 231 
respectively (Figure 1B). 232 
The preventive effect of ATRA on the TNFα-mediated proinflammatory cytokine expression was also 233 
evaluated in the human adipocyte culture supernatants. An increase in protein secretion was obtained for 234 
CXCL1, CXCL10 and midkine under TNFα treatment (168%, 173% and 118%, respectively). Their levels 235 
were significantly decreased in adipocytes pretreated with ATRA followed by TNFα incubation compared 236 
with TNFα alone (18%, 68% and 23.7%, respectively) (Figure 1C). 237 
 238 
2.2. ATRA supplementation limits cytokine/chemokine expression induced by LPS in mice adipose 239 
tissue. 240 
The effects of ATRA on cytokine/chemokine expression were studied in a model of acute inflammation, 241 
consisting of an intraperitoneal injection of LPS for 4 h in mice. As shown in Figure 2A, a significant 242 
increase in the mRNA expression levels of Il6 (8667%), Tnfα (1180%) and Il1β (360%) was observed in 243 
epididymal fat pads under the LPS effect, whereas a 4-day ATRA supplementation prior to LPS stimulation 244 
significantly reduced inflammation in white adipose tissue 37.4%, 38.5% and 43.9%, respectively (Figure 245 
2A). Chemokine mRNA including Ccl2, Ccl5, Ccl11, Ccl19, Cxcl1, Cx3cl1 and Cxcl10 were also 246 
quantified. Their expression was significantly increased by LPS (4412%, 7097%, 547%, 956%, 3150%, 247 
320%, 31944%, respectively) and reduced by 4 days of ATRA supplementation (55.3%, 56.3%, 54%, 66%, 248 
36.2%, 75.7% and 66.6%, respectively) (Figure 2A). 249 
We confirmed the preventive effect of ATRA on the LPS-mediated inflammation in the plasma mice. An 250 
increase in protein secretion was obtained for Il6, TNFα and Ccl5 after LPS intraperitoneal injection in 251 
mice (288.4%,  404% and 5597%, respectively) (Figure 2B). Their levels were significantly decreased in 252 
the plasma of mice that received ATRA by gavage followed by LPS injection compared with LPS alone 253 
(46.2%, 14% and 13.5%, respectively) (Figure 2B). We obtained similar results in the epididymal adipose 254 
tissue of these mice for Ccl2 and Ccl5, which increased in LPS-injected mice (275% and 30%, respectively) 255 
(Figure 2C). Interestingly, their levels were significantly decreased in epididymal adipose tissue of mice 256 
that received ATRA by gavage followed by LPS injection compared with LPS alone (24.2% and 15.8%, 257 
respectively) (Figure 2C). 258 
 259 
2.3. ATRA limits RAW 264.7 macrophage migration in 3T3-L1 conditioned medium. 260 
To examine the potential of ATRA to limit the migration of macrophages, 3T3-L1 cells were preincubated 261 
with ATRA (0.2 and 2 µM) prior to TNFα incubation, and compared with cells incubated with TNFα alone. 262 
The resulting 3T3-L1 conditioned medium was used to study the RAW 264.7 macrophage migration. As 263 
expected, 3T3-L1 conditioned medium under TNFα pro-inflammatory stimulus induced a significant 264 
migration of macrophages (approximately 100%, Figure 3). Interestingly, the preincubation of 3T3-L1 with 265 
2 µM of ATRA significantly reduced the migration of macrophages 26.3% (Figure 3). 266 
 267 
2.4. ATRA limits NF-κB activation in 3T3-L1 adipocytes. 268 
As previously demonstrated, the expression of several chemokines is upregulated in inflammatory 269 
conditions, mainly via the NF-κB signaling pathway in human adipocytes [4], and in 3T3-L1 adipocytes 270 
[23]. Since NF-κB activation is central in the induction of chemokines, we next examined whether the effect 271 
of ATRA on chemokine production could be mediated through limitation of NF-κB signaling in murine 272 
adipocytes. Cells were pretreated with ATRA for 24 h followed by a 5 min incubation with TNFα. As 273 
expected, phosphorylation levels of p65 and IκB, two subunits of the NF-κB pathway, were significantly 274 
increased in the inflammatory condition induced by TNFα (414% and 360%, respectively). On the other 275 
hand, preincubation of cells with ATRA strongly limited the phosphorylation of p65 and IκB, suggesting 276 
that ATRA was able to reduce NF-κB activation in 3T3-L1 adipocytes (Figure 4). 277 
 278 
2.5. ATRA modulates NF-κB signaling and cytokine/chemokine expression through PGC1α in 3T3-279 
L1 adipocytes. 280 
To identify the molecular mechanisms involved in ATRA-mediated NF-κB signaling deactivation, we 281 
hypothesized the involvement of PGC1α and/or β, since we had recently shown that ATRA induced the 282 
expression of PGC1α and PGC1β in 3T3-L1 adipocytes [12], and these transcription factors are known to 283 
reduce NF-κB activity in muscle cells [26]. 284 
The involvement of PGC1α and/or β on cytokine/chemokine modulation by ATRA was investigated in 285 
3T3-L1 adipocytes transfected with siRNA designed against PGC1α or PGC1β. The cells were then 286 
preincubated with ATRA for 24 h followed by an incubation with TNFα for 24 h (Figure 5A). As expected, 287 
TNFα treatment significantly increased the mRNA expression levels of Tnfα, Il6, Ccl2, Ccl5, Ccl11 and 288 
Cxcl10 (521%, 424%, 4420%, 3791%, 232% and 2787%, respectively), whereas ATRA incubation 289 
significantly decreased them (48.4%, 35%, 17%, 41.8%, 26.8% and 43%, respectively) compared with the 290 
TNFα condition (Figure 5A). Interestingly, in the 3T3-L1 adipocytes transfected with PGC1α siRNA, there 291 
was a modulation in the expression of these inflammatory markers (Tnfα, Il6, Ccl2, Ccl5, Ccl11 and Cxcl10, 292 
211.9%, 160%, 154%, 189%, 160% and 196%, respectively compared with the ATRA+TNFα condition). 293 
However, in the 3T3-L1 adipocytes transfected with PGC1β siRNA, no difference in Tnfα, Ccl2, Ccl5 and 294 
Cxcl10 expression was observed compared with the ATRA+TNFα condition, whereas the Il6 and Ccl11 295 
decrease mediated by ATRA was slightly blunted (Figure 5A). These results suggest that the 296 
cytokine/chemokine downregulation mediated by ATRA in inflamed adipocytes is mainly PGC1α-297 
dependent.  298 
To further investigate the involvement of PGC1α in these regulations, we studied the effect of PGC1α 299 
overexpression on TNFα-mediated cytokine/chemokine expression (Figure 5B). PGC1α overexpression 300 
induced a significant decrease in Tnfα, Ccl2, Ccl11 and Cxcl10 expression (46.3%, 14.6%, 33.3% and 301 
13.3% compared with pCMX in the TNFα condition). However, in the case of Ccl5 and Il6 expression, no 302 
effect of PGC1α was observed. These data suggest that the upregulation of some cytokine/chemokine 303 
expression mediated by TNFα can be partly blunted by PGC1α. 304 
To confirm the effect of PGC1α on the NF-κB signaling pathway, cells transfected with pCMX-PGC1α 305 
were incubated with or without TNFα for 5 min, and IκB phosphorylation was evaluated. As expected, 306 
TNFα treatment significantly increased the IκB phosphorylation  by 30% (Figure 6). Interestingly, PGC1α 307 
overexpression in adipocytes significantly decreased IκB phosphorylation  by 18.4% compared with TNFα-308 
treated adipocytes, suggesting that PGC1α overexpression is able to deactivate NF-κB signaling in 309 
adipocytes (Figure 6).  310 
 311 
 312 
3. Discussion 313 
 314 
Here we studied the putative role of ATRA on inflammatory marker expression in adipocytes and in adipose 315 
tissue, together with the molecular mechanisms involved  316 
To evaluate the impact of ATRA on the adipocyte inflammatory response, we used both human and murine 317 
mature adipocyte cultures subjected to TNFα incubation (to induce a low-grade inflammation). Analyses 318 
were conducted using high-throughput methods (microarrays and proteome profiler) combined with 319 
bioinformatic analysis of gene set enrichment. This approach demonstrated the ability of ATRA treatment 320 
to downregulate the expression of TNFα-mediated chemokine expression (at mRNA level and at protein 321 
level in some cases). Numerous genes coding for chemokines were impacted, among which Ccl2 [27], Ccl5 322 
[28, 29], C-x-c motif chemokine ligand 5 (Cxcl5 [30]), Cxcl12 [31], Cxcl14 [32], and Ccl20, which are 323 
known to be involved in leukocyte recruitment in adipose tissue [33]. Several chemokine receptors were 324 
also downregulated, which may add to the physiological consequences of ATRA-mediated chemokine 325 
downregulation. The impact of these regulations was also evaluated in terms of leukocyte chemotaxis [34], 326 
since chemokines mediate this process, and we found that ATRA limited macrophage migration induced 327 
by adipocyte-conditioned medium, which gives our results a functional validation.  328 
 329 
To confirm the physiological relevance of these regulations, mice underwent oral gavage of ATRA for 4 330 
days and were injected with LPS to induce inflammation, both at the systemic level and in adipose tissue. 331 
In these conditions, not only were adipose tissue mRNA levels of inflammatory markers reduced, but so 332 
also was adipose tissue protein expression (Ccl2 and Ccl5). It is also of note that this improvement in 333 
adipose tissue inflammatory status was associated with a reduced systemic inflammatory tone, as shown by 334 
the reduction of several inflammatory markers, such as Il6, Tnfα and Ccl5. Surprisingly, our results diverge 335 
from the recent finding of a moderate increase in proinflammatory markers (Il18 and MIP-1γ) in male mice 336 
subjected to a moderate vitamin A supplementation [35]. This discrepancy may derive from the major 337 
differences between the two experimental protocols (use of vitamin A or ATRA, duration of treatment, 338 
concentrations of substances used, etc.). However, our results seem to be in line with the suspected role of 339 
vitamin A deficiency in elevated proinflammatory cytokines and T-cell activation [36, 37]. 340 
 341 
From a molecular point of view, it is well-established that NF-κB controls the transcription of 342 
proinflammatory cytokines and chemokines in many cell types, including preadipocytes and adipocytes [1, 343 
4, 38]. Thus we evaluated the ability of ATRA to blunt NF-κB-mediated chemokine expression. First we 344 
demonstrated that ATRA displayed a strong inhibitory effect on NF-κB signaling in 3T3-L1 adipocytes, 345 
characterized by reduced phosphorylation levels of IκB and p65 (two main intermediates in the NF-κB 346 
signaling pathway).  347 
Similar inhibition of NF-κB signaling has already been reported in various cell models [39], and in 348 
transgenic NF-κB reporter mice [40]. To pursue the identification of the precise molecular mechanisms, we 349 
hypothesized the involvement of PGC1α and/or PGC1β. Peroxisome proliferator-activated receptor γ 350 
coactivator 1 α and β are members of the PGC1 family of transcriptional coactivators [41]. PGC1α is mainly 351 
involved in adaptive thermogenesis, glucose disposal and mitochondrial biogenesis [42], whereas PGC1β 352 
regulates saturated fatty acid-induced hepatic triglyceride synthesis and hyperlipidemia [43], and 353 
mitochondrial fatty acid β oxidation [44]. In addition, these two transcription factors are able to reduce 354 
phosphorylation of the NF-κB family member p65 and thereby its transcriptional activation potential in 355 
muscle cells [26], and we recently showed that ATRA upregulated the two transcription factors in 3T3-L1 356 
adipocytes [12]. To confirm the involvement of PGC1α and/or β in cytokine/chemokine downregulation, 357 
siRNA designed against PGC1α and PGC1β was used. Results clearly show that inflammatory marker 358 
limitation through ATRA was primarily mediated by PGC1α, the ATRA downregulation of chemokines 359 
being abolished in the presence of siRNA directed against PGC1α. Furthermore, the ability of PGC1α to 360 
repress the TNFα-mediated upregulation of chemokine mRNA levels together with NF-κB signaling, and 361 
notably IκB phosphorylation, was confirmed in overexpression experiments. Taken together, these findings 362 
strongly support the involvement of the ATRA-mediated upregulation of PGC1α in the inhibition of NF-363 
κB signaling and subsequent limitation of chemokine expression. However, other putative mechanisms 364 
cannot be excluded, notably the ATRA-mediated upregulation of specific phosphatases leading to NF-κB 365 
signaling deactivation, similar to the anti-inflammatory effect of the 1,25(OH)2D, which is mediated in 366 
particular via an induction of Dusp10 [24], a phosphatase involved in stress-activated kinase 367 
dephosphorylation.  368 
 369 
Data related to the impact of retinoic acid on inflammation in humans are particularly scant, but it is 370 
noteworthy that in a recent prospective study, an inverse association between retinoic acid (RA) with several 371 
inflammatory and oxidative stress biomarkers such as 8-iso-prostaglandin F2α, C Reactive Protein and IL6 372 
was reported in a Chinese metabolic syndrome population [45]. Even if our results seem to be encouraging, 373 
and in agreement with a clinical study, our data present several limitations due to the supraphysiological 374 
doses of ATRA used both in vitro and in vivo, and to the fact that extrapolation from mice to human is 375 
sometimes hazardous. 376 
In conclusion, the results of the present study show that ATRA reduces chemokine expression in adipocytes 377 
and macrophage migration in vitro. We confirmed these results in mice adipose tissue. These effects may 378 
be associated with the ability of ATRA to limit the activation of the NF-κB signaling pathway, probably 379 
through PGC1α.  380 
 381 
 382 
 383 
 384 
 385 
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 393 
Figure 1. ATRA decreases chemokine expression levels in adipocytes. Cells were preincubated with 394 
ATRA (2 µM) for 24 h and incubated with TNFα (15 ng/mL) for 24 h. A. The mRNA levels of CCL5, 395 
CCL19, CXCL1, CX3CL1, CXCL5 and CXCL10 were quantified through qPCR in human adipocytes. The 396 
values are presented as means ± SEM. Experiments were performed in triplicate, on 3 independent cultures. 397 
B. The mRNA levels of Ccl5, Ccl19, Cxcl1, Cx3xl1 and Cxcl10 were quantified through qPCR in 3T3-L1 398 
adipocytes. The values are presented as means ± SEM. Experiments were performed in triplicate, on 3 399 
independent cultures. C. CXCL10, CXCL1 and Midkine secretion in cell culture supernatants of human 400 
adipocytes was quantified by Luminex technology and Proteome Profiler Array. n.d.: not detected. Bars not 401 
sharing the same letters are significantly different, p < 0.05. 402 
 403 
Figure 2. ATRA decreases chemokine expression levels in LPS-mediated inflammation in mice 404 
epididymal adipose tissue. A. In an acute inflammation model (LPS injection for 4 h), the mRNA levels 405 
of Il6, Tnfα, Il1β, Ccl2, Ccl5, Ccl11, Ccl19, Cxcl1, Cx3cl1 and Cxcl10 were quantified through qPCR in 406 
epididymal adipose tissue of mice (n = 6–9 per group), and expressed relative to 18S ribosomal RNA. The 407 
data are expressed as relative expression ratios. The values are presented as means ± SEM. Bars not sharing 408 
the same letters are significantly different, p < 0.05. B. In the LPS inflammation model, protein amounts of 409 
Il6, Tnfα and Ccl5 secreted were quantified by ELISA. The data are expressed as relative expression ratios. 410 
The values are presented as means ± SEM. Bars not sharing the same letters are significantly different, p < 411 
0.05. C. In the LPS inflammation model, protein amounts of Ccl2 and Ccl5 in epididymal adipose tissue of 412 
mice were quantified by ELISA. The data are expressed as relative expression ratios. The values are 413 
presented as means ± SEM. Bars not sharing the same letters are significantly different, p < 0.05. 414 
 415 
Figure 3. ATRA decreases macrophage migration in 3T3-L1 adipocytes. 3T3-L1 cells were 416 
preincubated with ATRA (0.2 and 2 µM) for 24 h, and incubated with TNFα (15 ng/mL) for 24 h. RAW 417 
264.7 macrophage migration in 3T3-L1 conditioned media (4 h, 37 °C) was then performed. Data are 418 
expressed as relative expression ratio. Values are presented as means ± SEM. Bars not sharing the same 419 
letter are significantly different, p < 0.05. Experiments were performed in triplicate, on 3 independent 420 
cultures. 421 
 422 
Figure 4. ATRA limits NF-κB activation. Cells were preincubated with ATRA (1 and 2 µM) for 24 h 423 
dose-dependently, and incubated with TNFα (15 ng/mL) for 5 min. Phosphorylation levels of the NF-κB 424 
subunits (p65 and IκB) were evaluated by ELISA. Data are expressed as relative expression ratio. Values 425 
are presented as means ± SEM. Bars not sharing the same letter are significantly different, p < 0.05. 426 
Experiments were performed in triplicate, on 3 independent cultures. 427 
 428 
Figure 5. ATRA modulates NF-κB signaling and cytokine/chemokine expression through PGC1α in 429 
3T3-L1 adipocytes. A. Cells were transfected with siRNA designed against PGC1α or PGC1β or with 430 
nontargeted siRNA. The cells were then preincubated with ATRA for 24 h followed by an incubation with 431 
TNFα for 24 h. The mRNA levels of Tnfα, Il6, Ccl2, Ccl5, Ccl11 and Cxcl10 were quantified through 432 
qPCR. The values are presented as means ± SEM. B. Cells were transfected with pCMX plasmids, empty 433 
or containing PGC1α (pCMX-PGC1α). After 24h incubation, cells were incubated with TNFα for 24 h. The 434 
mRNA levels of Tnfα, Il6, Ccl2, Ccl5, Ccl11 and Cxcl10 were quantified through qPCR. Values are 435 
presented as means ± SEM. Bars not sharing the same letter are significantly different, p < 0.05. Each 436 
experiment was reproduced in triplicate, at least 3 independent times. 437 
 438 
Figure 6. PGC1α limits IκB phosphorylation in 3T3-L1 adipocytes. Cells were transfected with pCMX 439 
plasmids, empty or containing PGC1α (pCMX-PGC1α). After 24 h incubation, cells were incubated with 440 
TNFα for 5 min. Phosphorylation levels of IκB were evaluated by ELISA. Data are expressed as relative 441 
expression ratio. Values are presented as means ± SEM. Bars not sharing the same letter are significantly 442 
different, p < 0.05. Experiments were performed in triplicate, on 3 independent cultures. 443 
 444 
 445 
 446 
 447 
 448 
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